Literature DB >> 12646021

Discovery of tyrosine-based potent and selective melanocortin-1 receptor small-molecule agonists with anti-inflammatory properties.

Timothy F Herpin1, Guixue Yu, Kenneth E Carlson, George C Morton, Ximao Wu, Liya Kang, Huji Tuerdi, Ashish Khanna, John S Tokarski, R Michael Lawrence, John E Macor.   

Abstract

The melanocortin-1 receptor (MC-1R) is a G-protein-coupled receptor involved in inflammation and skin pigmentation. Compound 2 is the first highly potent and selective MC-1R small-molecule agonist reported. Compound 2 showed efficacy in an acute model of inflammation, which has demonstrated the role of MC-1R in modulation of inflammation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646021     DOI: 10.1021/jm025600i

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists.

Authors:  Irina D Pogozheva; Biao-Xin Chai; Andrei L Lomize; Tung M Fong; David H Weinberg; Ravi P Nargund; Michael W Mulholland; Ira Gantz; Henry I Mosberg
Journal:  Biochemistry       Date:  2005-08-30       Impact factor: 3.162

2.  Design, synthesis, and biological evaluation of a new class of small molecule peptide mimetics targeting the melanocortin receptors.

Authors:  James P Cain; Alexander V Mayorov; Minying Cai; Hui Wang; Bahar Tan; Kevin Chandler; YeonSun Lee; Ravil R Petrov; Dev Trivedi; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2006-08-22       Impact factor: 2.823

Review 3.  The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases.

Authors:  Minying Cai; Victor J Hruby
Journal:  Curr Protein Pept Sci       Date:  2016       Impact factor: 3.272

4.  The melanoma-linked "redhead" MC1R influences dopaminergic neuron survival.

Authors:  Xiqun Chen; Hongxiang Chen; Waijiao Cai; Michael Maguire; Bailiu Ya; Fuxing Zuo; Robert Logan; Hui Li; Katey Robinson; Charles R Vanderburg; Yang Yu; Yinsheng Wang; David E Fisher; Michael A Schwarzschild
Journal:  Ann Neurol       Date:  2017-01-23       Impact factor: 10.422

5.  The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature.

Authors:  G Leoni; M-B Voisin; K Carlson; Sj Getting; S Nourshargh; M Perretti
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

6.  Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways.

Authors:  J R Doyle; J P Fortin; M Beinborn; A S Kopin
Journal:  J Pharmacol Exp Ther       Date:  2012-04-30       Impact factor: 4.030

7.  Opioid and melanocortin receptors: do they have overlapping pharmacophores?

Authors:  Yeon Sun Lee; Richard S Agnes; James P Cain; Vinod Kulkarni; Minying Cai; Christine Salibay; Kathy Ciano; Ravil Petrov; Alexander Mayorov; Josef Vagner; Dev Trivedi; Peg Davis; Shou-wu Ma; Josephine Lai; Frank Porreca; Ruben Vardanyan; Victor J Hruby
Journal:  Biopolymers       Date:  2008       Impact factor: 2.505

Review 8.  Design, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptor.

Authors:  Victor J Hruby; Minying Cai; James P Cain; Alexander V Mayorov; Matthew M Dedek; Devendra Trivedi
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

9.  Effects of melanocortin 1 receptor agonists in experimental nephropathies.

Authors:  Annika Lindskog Jonsson; Anna Granqvist; Johannes Elvin; Martin E Johansson; Börje Haraldsson; Jenny Nyström
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

10.  Effect of BMS-470539 on lipopolysaccharide-induced neutrophil activation.

Authors:  Seongheon Lee; Wan Ju; Tran Duc Tin; Joungmin Kim; Jeong Seok Lee; Cheon Hee Park; Sang Hyun Kwak
Journal:  Korean J Anesthesiol       Date:  2019-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.